Membranous nephropathy: when and how to treat
- PMID: 17457329
- DOI: 10.1038/sj.ki.5002201
Membranous nephropathy: when and how to treat
Abstract
The treatment of idiopathic membranous nephropathy is heavily debated because of wide variation in outcome. A rational treatment strategy is needed to appropriately administer conservative treatment to the low-risk group but immunosuppressive therapy to those with medium or high risk of renal deterioration. Currently, combinations of steroids with alkylating agents are best studied. Newer forms of immunosuppressive treatment are currently under study.
Comment on
-
Tacrolimus monotherapy in membranous nephropathy: a randomized controlled trial.Kidney Int. 2007 May;71(9):924-30. doi: 10.1038/sj.ki.5002215. Epub 2007 Mar 21. Kidney Int. 2007. PMID: 17377504 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
